Leading Pharma rakes in $40 mln
Leading Pharma LLC, a maker of generic drugs, has raised $40 million in funding. Signet Healthcare Partners led the round with participation from other backers that included Crestline Investors and Cane Investment Partners. In conjunction with the funding, Nikhil Puri, a managing director at Signet Healthcare Partners and Chris Semple, a managing director at Crestline Investors, will join the board of directors of Leading Pharma's parent company.
8 January 2018•1 min read
